Denisse Bretel
Overview
Explore the profile of Denisse Bretel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
261
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Araujo J, Gomez A, Jongh W, Ausejo J, Cordova I, Schwarz L, et al.
Ecancermedicalscience
. 2023 Feb;
17:1494.
PMID: 36816782
Introduction: A high prevalence of advanced breast cancer (BC) is a common scenario in Latin America. In Peru, the frequency of BC at Stages III/IV is ≈50% despite implementation of...
2.
Gossling G, Rebelatto T, Villarreal-Garza C, Ferrigno A, Bretel D, Sala R, et al.
Curr Oncol
. 2023 Jan;
30(1):653-662.
PMID: 36661699
In Latin America and the Caribbean (LAC), progress has been made in some national and regional cancer control initiatives, which have proved useful in reducing diagnostic and treatment initiation delays....
3.
Caglevic C, Rolfo C, Gil-Bazo I, Cardona A, Sapunar J, Hirsch F, et al.
JCO Glob Oncol
. 2022 Aug;
8:e2200123.
PMID: 35994695
On February 24, 2022, a war began within the Ukrainian borders. At least 3.0 million Ukrainian inhabitants have already fled the country. Critical infrastructure, including hospitals, has been damaged. Children...
4.
Lara Gongora A, Werutsky G, Jardim D, Nogueira-Rodrigues A, Barrios C, Mathias C, et al.
JCO Glob Oncol
. 2021 May;
7:649-658.
PMID: 33956499
Purpose: COVID-19 has affected cancer care worldwide. Clinical trials are an important alternative for the treatment of oncologic patients, especially in Latin America, where trials can be the only opportunity...
5.
Zevallos A, Bravo L, Bretel D, Paez K, Infante U, Cardenas N, et al.
Crit Rev Oncol Hematol
. 2020 Oct;
155:103094.
PMID: 33027724
Triple-negative breast cancer (TNBC) is a heterogeneous and complex disease characterized by the absence of immunohistochemical expression of estrogen receptor, progesterone receptor and HER2. These breast tumors present an aggressive...
6.
Pinto J, Vallejos C, Raez L, Mas L, Ruiz R, Torres-Roman J, et al.
ESMO Open
. 2018 Apr;
3(3):e000344.
PMID: 29682332
Background: There are well-known differences in gender outcome in non-small cell lung cancer (NSCLC) and other cancers. In this work, we evaluated several randomised clinical trials to explore the gender...
7.
Araujo J, Gomez A, Aguilar A, Salgado R, Balko J, Bravo L, et al.
Sci Rep
. 2018 Mar;
8(1):4899.
PMID: 29559701
Triple negative breast cancer (TNBC) is the most aggressive form of breast cancer with limited options of targeted therapy. Recent findings suggest that the clinical course of TNBC may be...
8.
Pinto J, Rolfo C, Raez L, Prado A, Araujo J, Bravo L, et al.
Sci Rep
. 2017 May;
7(1):1526.
PMID: 28484222
DDIT4 gene encodes a protein whose main action is to inhibit mTOR under stress conditions whilst several in vitro studies indicate that its expression favors cancer progression. We have previously...
9.
Rolfo C, Caglevic C, Bretel D, Hong D, Raez L, Cardona A, et al.
ESMO Open
. 2016 Nov;
1(4):e000055.
PMID: 27843620
Latin America and the Caribbean have not yet developed strong clinical cancer research programmes. In order to improve this situation two international cancer organisations, the Latin American Society of Clinical...